This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144: 1941-53. doi: 10.1002/ijc.31937FerlayJColombetMSoerjomataramIMathersCParkinDMPiñerosMet alEstimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInt J Cancer201914419415310.1002/ijc.3193730350310Open DOISearch in Google Scholar
Maciejczyk A, Skrzypczyńska I, Janiszewska M. Lung cancer. Radiotherapy in lung cancer: actual methods and future trends. Reports Pract Oncol Radiother 2014; 19: 35360. doi: 10.1016/j.rpor.2014.04.012MaciejczykASkrzypczyńskaIJaniszewskaMLung cancerRadiotherapy in lung cancer: actual methods and future trends. Reports Pract Oncol Radiother2014193536010.1016/j.rpor.2014.04.012420177625337407Open DOISearch in Google Scholar
Videtic GMM., Donington J., Giuliani M., et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 2017; 7: 295-301. doi: 10.1016/j.prro.2017.04.014VideticGMM.DoningtonJ.GiulianiM.et alStereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO Evidence-Based GuidelinePract Radiat Oncol2017729530110.1016/j.prro.2017.04.01428596092Open DOISearch in Google Scholar
Cheng M, Jolly S, Quarshie WO, Kapadia N, Vigneau FD, Kong FM. Modern radiation further improves survival in non-small cell lung cancer: an analysis of 288,670 patients. J Cancer 2019; 10: 168-77. doi: 10.7150/jca.26600ChengMJollySQuarshieWOKapadiaNVigneauFDKongFMModern radiation further improves survival in non-small cell lung cancer: an analysis of 288,670 patientsJ Cancer2019101687710.7150/jca.26600632984830662537Open DOISearch in Google Scholar
Vinod SK, Hau E. Radiotherapy treatment for lung cancer: current status and future directions. Respirology 2020; 25(Suppl 2): 61-71. doi: 10.1111/resp.13870VinodSKHauERadiotherapy treatment for lung cancer: current status and future directionsRespirology202025Suppl 2617110.1111/resp.1387032516852Open DOISearch in Google Scholar
Shah JL, Loo BW. Stereotactic ablative radiotherapy for early-stage lung cancer. Semin Radiat Oncol 2017; 27: 218-28. doi: 10.1016/j.semradonc.2017.03.001ShahJLLooBWStereotactic ablative radiotherapy for early-stage lung cancerSemin Radiat Oncol2017272182810.1016/j.semradonc.2017.03.00128577829Open DOISearch in Google Scholar
Tian S, Higgins KA, Curran WJ, Cassidy RJ. Stereotactic body radiation therapy vs. surgery in early-stage nonsmall cell lung cancer: lessons learned, current recommendations, future directions. J Thorac Dis 2018; 10: 1201-4. doi: 10.21037/jtd.2018.01.161TianSHigginsKACurranWJCassidyRJStereotactic body radiation therapy vssurgery in early-stage nonsmall cell lung cancer: lessons learned, current recommendations, future directions. J Thorac Dis2018101201410.21037/jtd.2018.01.161590637529708180Open DOISearch in Google Scholar
Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol 2018; 45: 2010-9. doi: 10.1053/j.seminoncol.2018.06.002ShindeALiRKimJSalgiaRHurriaAAminiAStereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderlySemin Oncol2018452010910.1053/j.seminoncol.2018.06.00230286944Open DOISearch in Google Scholar
Chi A, Fang W, Sun Y, Wen S. Comparison of long-term survival of patients with early-stage non-small cell lung cancer after surgery vs stereotactic body radiotherapy. JAMA Netw Open 2019; 2: e1915724. doi: 10.1001/jamanetworkopen.2019.15724ChiAFangWSunYWenSComparison of long-term survival of patients with early-stage non-small cell lung cancer after surgery vs stereotactic body radiotherapyJAMA Netw Open20192e191572410.1001/jamanetworkopen.2019.15724690281331747032Open DOISearch in Google Scholar
Lagerwaard FJ, Haasbeek CJA, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70: 685-92. doi: 10.1016/j.ijrobp.2007.10.053LagerwaardFJHaasbeekCJASmitEFSlotmanBJSenanSOutcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancerInt J Radiat Oncol Biol Phys2008706859210.1016/j.ijrobp.2007.10.05318164849Open DOISearch in Google Scholar
De Ruysscher D, Faivre-Finn C, Moeller D, Nestle U, Hurkmans CW, Le Péchoux C, et al. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol 2017; 124: 1-10. doi: 10.1016/j.radonc.2017.06.003De RuysscherDFaivre-FinnCMoellerDNestleUHurkmansCWLe PéchouxCet alEuropean Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancerRadiother Oncol201712411010.1016/j.radonc.2017.06.00328666551Open DOISearch in Google Scholar
Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Hoyer M, Hurkmans C, et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 2017; 124: 11-7. doi: 10.1016/j.radonc.2017.05.012GuckenbergerMAndratschkeNDieckmannKHoogemanMSHoyerMHurkmansCet alESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancerRadiother Oncol201712411710.1016/j.radonc.2017.05.01228687397Open DOISearch in Google Scholar
Temming S, Kocher M, Stoelben E, Hagmeyer L, Chang DH, Frank K, et al. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer. Strahlentherapie Und Onkol 2018; 194: 91-7. doi: 10.1007/s00066-017-1194-xTemmingSKocherMStoelbenEHagmeyerLChangDHFrankKet alRisk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancerStrahlentherapie Und Onkol201819491710.1007/s00066-017-1194-x28812120Open DOISearch in Google Scholar
de Jong EEC, Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Milder M, et al. Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91. Radiother Oncol 2020; 142: 217-23. doi: 10.1016/j.radonc.2019.11.001deJong EECGuckenbergerMAndratschkeNDieckmannKHoogemanMSMilderMet alVariation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91Radiother Oncol20201422172310.1016/j.radonc.2019.11.00131767472Open DOISearch in Google Scholar
Ruggieri R, Stavrev P, Naccarato S, Stavreva N, Alongi F, Nahum AE. Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis. Phys Medica 2017; 44: 188-95. doi: 10.1016/j.ejmp.2016.12.012RuggieriRStavrevPNaccaratoSStavrevaNAlongiFNahumAEOptimal dose and fraction number in SBRT of lung tumours: A radiobiological analysisPhys Medica2017441889510.1016/j.ejmp.2016.12.01228130055Open DOISearch in Google Scholar
Atalar B, Mustafayev TZ, Sio TT, Sahin B, Gungor G, Aydın G, et al. Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors. Radiol Oncol 2020; 54: 4807. doi: 10.2478/raon-2020-0039AtalarBMustafayevTZSioTTSahinBGungorGAydınGet alLong-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumorsRadiol Oncol202054480710.2478/raon-2020-0039758533432589607Open DOISearch in Google Scholar
Widder J, Hollander M, Ubbels JF, Bolt RA, Langendijk JA. Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation. Radiother Oncol 2010; 94: 42-6. doi: 10.1016/j.radonc.2009.11.008WidderJHollanderMUbbelsJFBoltRALangendijkJAOptimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculationRadiother Oncol20109442610.1016/j.radonc.2009.11.00820022394Open DOISearch in Google Scholar
Ewing MM, Desrosiers C, Fakiris AJ, DeBliek CR, Kiszka DN, Stinson ER, et al. Conformality study for stereotactic radiosurgery of the lung. Med Dosim 2011; 36: 14-20. doi: 10.1016/j.meddos.2009.10.004EwingMMDesrosiersCFakirisAJDeBliekCRKiszkaDNStinsonERet alConformality study for stereotactic radiosurgery of the lungMed Dosim201136142010.1016/j.meddos.2009.10.00420110162Open DOISearch in Google Scholar
Chan M, Wong M, Leung R, Cheung S, Blanck O. Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation. Radiat Oncol 2018; 13: 1-11. doi: 10.1186/s13014-018-0965-6ChanMWongMLeungRCheungSBlanckOOptimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalationRadiat Oncol20181311110.1186/s13014-018-0965-6580782329426358Open DOISearch in Google Scholar
Meng MB, Wang HH, Zaorsky NG, Sun BS, Zhu L, Song YC, et al. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer. Cancer Sci 2019; 110: 3553-64. doi: 10.1111/cas.14185MengMBWangHHZaorskyNGSunBSZhuLSongYCet alRisk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancerCancer Sci201911035536410.1111/cas.14185682501231464032Open DOISearch in Google Scholar
Tsurugai Y, Takeda A, Sanuki N, Eriguchi T, Aoki Y, Oku Y, et al. Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume. J Radiat Res 2019; 60: 364-70. doi: 10.1093/jrr/rry112TsurugaiYTakedaASanukiNEriguchiTAokiYOkuYet alStereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volumeJ Radiat Res2019603647010.1093/jrr/rry112653062730668868Open DOISearch in Google Scholar
Oku Y, Takeda A, Kunieda E, Sudo Y, Oooka Y, Aoki Y, et al. Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Pract Radiat Oncol 2012; 2: 46-53. doi: 10.1016/j.prro.2011.06.001OkuYTakedaAKuniedaESudoYOookaYAokiYet alAnalysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapyPract Radiat Oncol20122465310.1016/j.prro.2011.06.00124674036Open DOISearch in Google Scholar
Ding C, Solberg T, Xing L, Heinzerling J, Timmerman R. SU-E-T-451: optimization of normalized prescription isodose selection for stereotactic radiation therapy: conventional vs. robotic linac. Med Phys 2012; 39: 3808-9. doi: 10.1118/1.4735540DingCSolbergTXingLHeinzerlingJTimmermanRSU-E-T-451: optimization of normalized prescription isodose selection for stereotactic radiation therapy: conventional vsrobotic linac. Med Phys2012393808910.1118/1.473554028517448Open DOISearch in Google Scholar
Zheng D, Zhang Q, Liang X, Zhu X, Verma V, Wang S, et al. Effect of the normalized prescription isodose line on the magnitude of Monte Carlo vs. pencil beam target dose differences for lung stereotactic body radiotherapy. J Appl Clin Med Phys 2016; 17: 48-58. doi: 10.1120/jacmp.v17i4.5965ZhengDZhangQLiangXZhuXVermaVWangSet alEffect of the normalized prescription isodose line on the magnitude of Monte Carlo vspencil beam target dose differences for lung stereotactic body radiotherapy. J Appl Clin Med Phys201617485810.1120/jacmp.v17i4.5965569005327455476Open DOISearch in Google Scholar
Dickey M, Roa W, Drodge S, Ghosh S, Murray B, Scrimger R, et al. A planning comparison of 3-dimensional conformal multiple static field, conformal arc, and volumetric modulated arc therapy for the delivery of stereotactic body radiotherapy for early stage lung cancer. Med Dosim 2015; 40: 347-51. doi: 10.1016/j.meddos.2015.04.006DickeyMRoaWDrodgeSGhoshSMurrayBScrimgerRet alA planning comparison of 3-dimensional conformal multiple static field, conformal arc, and volumetric modulated arc therapy for the delivery of stereotactic body radiotherapy for early stage lung cancerMed Dosim2015403475110.1016/j.meddos.2015.04.00626027510Open DOISearch in Google Scholar
Schwarz M, Cattaneo GM, Marrazzo L. Geometrical and dosimetrical uncertainties in hypofractionated radiotherapy of the lung: a review. Phys Medica 2017; 36: 126-39. doi: 10.1016/j.ejmp.2017.02.011SchwarzMCattaneoGMMarrazzoLGeometrical and dosimetrical uncertainties in hypofractionated radiotherapy of the lung: a reviewPhys Medica2017361263910.1016/j.ejmp.2017.02.01128238577Open DOISearch in Google Scholar
Younge KC, Roberts D, Janes LA, Anderson C, Moran JM, Matuszak MM. Predicting deliverability of volumetric-modulated arc therapy (VMAT) plans using aperture complexity analysis. J Appl Clin Med Phys 2016; 17: 124-31. doi: 10.1120/jacmp.v17i4.6241YoungeKCRobertsDJanesLAAndersonCMoranJMMatuszakMMPredicting deliverability of volumetric-modulated arc therapy (VMAT) plans using aperture complexity analysisJ Appl Clin Med Phys2016171243110.1120/jacmp.v17i4.6241534548427455504Open DOISearch in Google Scholar
Yaparpalvi R, Garg MK, Shen J, Bodner WR, Mynampati DK, Gafar A, et al. Evaluating which plan quality metrics are appropriate for use in lung SBRT. Br J Radiol 2018; 91: 1-8. doi: 10.1259/bjr.20170393YaparpalviRGargMKShenJBodnerWRMynampatiDKGafarAet alEvaluating which plan quality metrics are appropriate for use in lung SBRTBr J Radiol2018911810.1259/bjr.20170393596548529227151Open DOISearch in Google Scholar
Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006; 64: 333-42. doi: 10.1016/j.ijrobp.2005.09.028FeuvretLNoëlGMazeronJJBeyPConformity index: a reviewInt J Radiat Oncol Biol Phys2006643334210.1016/j.ijrobp.2005.09.02816414369Open DOISearch in Google Scholar
Esch A Van, Huyskens DP, Hirschi L, Scheib S, Baltes C. Optimized varian aSi portal dosimetry: development of datasets for collective use. J Appl Clin Med Phys 2013; 14: 82-99. doi: 10.1120/jacmp.v14i6.4286EschA VanHuyskensDPHirschiLScheibSBaltesCOptimized varian aSi portal dosimetry: development of datasets for collective useJ Appl Clin Med Phys201314829910.1120/jacmp.v14i6.4286571463524257272Open DOISearch in Google Scholar
Moghadam SE, Nasseri S, Seyedi SS, Gholamhosseinian H, Momennezhad M. Evaluation of application of EPID for rapid QC testing of linear accelerator. Reports Pract Oncol Radiother 2018; 23: 369-77. doi: 10.1016/j.rpor.2018.07.008MoghadamSENasseriSSeyediSSGholamhosseinianHMomennezhadMEvaluation of application of EPID for rapid QC testing of linear acceleratorReports Pract Oncol Radiother2018233697710.1016/j.rpor.2018.07.008609740730127677Open DOISearch in Google Scholar
Min S, Choi YE, Kwak J, Cho B. Practical approach for pretreatment verification of IMRT with flattening filter-free (FFF) beams using varian portal dosimetry. J Appl Clin Med Phys 2015; 16: 40-50. doi: 10.1120/jacmp.v16i1.4934MinSChoiYEKwakJChoBPractical approach for pretreatment verification of IMRT with flattening filter-free (FFF) beams using varian portal dosimetryJ Appl Clin Med Phys201516405010.1120/jacmp.v16i1.4934568998725679149Open DOISearch in Google Scholar
Barbeiro AR, Parent L, Vieillevigne L, Ferrand R, Franceries X. Dosimetric performance of continuous EPID imaging in stereotactic treatment conditions. Phys Medica 2020; 78: 117-22. doi: 10.1016/j.ejmp.2020.09.009BarbeiroARParentLVieillevigneLFerrandRFranceriesXDosimetric performance of continuous EPID imaging in stereotactic treatment conditionsPhys Medica2020781172210.1016/j.ejmp.2020.09.00932980588Open DOISearch in Google Scholar
Xu Z, Kim J, Han J, Hsia AT, Ryu S. Dose rate response of digital megavolt imager detector for flattening filter-free beams. J Appl Clin Med Phys 2018; 19: 141-7. doi: 10.1002/acm2.12358XuZKimJHanJHsiaATRyuSDose rate response of digital megavolt imager detector for flattening filter-free beamsJ Appl Clin Med Phys201819141710.1002/acm2.12358603639929781165Open DOISearch in Google Scholar
Pardo E, Novais JC, López MYM, Maqueda SR. On flattening filter-free portal dosimetry. J Appl Clin Med Phys 2016; 17: 132-45. doi: 10.1120/jacmp.v17i4.6147PardoENovaisJCLópezMYMMaquedaSROn flattening filter-free portal dosimetryJ Appl Clin Med Phys2016171324510.1120/jacmp.v17i4.6147569003927455487Open DOISearch in Google Scholar
Miri N, Keller P, Zwan BJ, Greer P. EPID-based dosimetry to verify IMRT planar dose distribution for the aS1200 EPID and FFF beams. J Appl Clin Med Phys 2016; 17: 292-304. doi: 10.1120/jacmp.v17i6.6336MiriNKellerPZwanBJGreerPEPID-based dosimetry to verify IMRT planar dose distribution for the aS1200 EPID and FFF beamsJ Appl Clin Med Phys20161729230410.1120/jacmp.v17i6.6336569049427929502Open DOISearch in Google Scholar
Xia Y, Adamson J, Zlateva Y, Giles W. Application of TG-218 action limits to SRS and SBRT pre-treatment patient specific QA. J Radiosurgery SBRT 2020; 7: 135-47. PMID: 33282467XiaYAdamsonJZlatevaYGilesWApplication of TG-218 action limits to SRS and SBRT pre-treatment patient specific QAJ Radiosurgery SBRT2020713547PMID: 33282467Search in Google Scholar
Alharthi T, Arumugam S, Vial P, Holloway L, Thwaites D. EPID sensitivity to delivery errors for pre-treatment verification of lung SBRT VMAT plans. Phys Medica 2019; 59: 37-46. doi: 10.1016/j.ejmp.2019.02.007AlharthiTArumugamSVialPHollowayLThwaitesDEPID sensitivity to delivery errors for pre-treatment verification of lung SBRT VMAT plansPhys Medica201959374610.1016/j.ejmp.2019.02.00730928064Open DOISearch in Google Scholar
Son J, Baek T, Lee B, Shin D, Park SY, Park J, et al. A comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapy. Radiol Oncol 2015; 49: 307-13. doi: 10.1515/raon-2015-0021SonJBaekTLeeBShinDParkSYParkJet alA comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapyRadiol Oncol2015493071310.1515/raon-2015-0021457722926401138Open DOISearch in Google Scholar
Radojcic DS, Rajlic D, Casar B, Kolacio MS, Obajdin N, Faj D, et al. Evaluation of two-dimensional dose distributions for pre-treatment patient-specific IMRT dosimetry. Radiol Oncol 2018; 52: 346-52. doi: 10.2478/raon-2018-0019RadojcicDSRajlicDCasarBKolacioMSObajdinNFajDet alEvaluation of two-dimensional dose distributions for pre-treatment patient-specific IMRT dosimetryRadiol Oncol2018523465210.2478/raon-2018-0019613735630210046Open DOISearch in Google Scholar
Hernandez V, Saez J, Pasler M, Jurado-Bruggeman D, Jornet N. Comparison of complexity metrics for multi-institutional evaluations of treatment plans in radiotherapy. Phys Imaging Radiat Oncol 2018; 5: 37-43. doi: 10.1016/j.phro.2018.02.002HernandezVSaezJPaslerMJurado-BruggemanDJornetNComparison of complexity metrics for multi-institutional evaluations of treatment plans in radiotherapyPhys Imaging Radiat Oncol20185374310.1016/j.phro.2018.02.002780758833458367Open DOISearch in Google Scholar
Chiavassa S, Bessieres I, Edouard M, Mathot M, Moignier A. Complexity metrics for IMRT and VMAT plans: a review of current literature and applications. Br J Radiol 2019; 92. doi: 10.1259/bjr.20190270ChiavassaSBessieresIEdouardMMathotMMoignierAComplexity metrics for IMRT and VMAT plans: a review of current literature and applicationsBr J Radiol20199210.1259/bjr.20190270677459931295002Open DOISearch in Google Scholar
Xu Z, Wang IZ, Kumaraswamy LK, Podgorsak MB. Evaluation of dosimetric effect caused by slowing with multi-leaf collimator (MLC) leaves for volumetric modulated arc therapy (VMAT). Radiol Oncol 2016; 50: 121-8. doi: 10.1515/raon-2016-0008XuZWangIZKumaraswamyLKPodgorsakMBEvaluation of dosimetric effect caused by slowing with multi-leaf collimator (MLC) leaves for volumetric modulated arc therapy (VMAT)Radiol Oncol201650121810.1515/raon-2016-0008482533427069458Open DOISearch in Google Scholar
Park JM, Park SY, Kim H. Modulation index for VMAT considering both mechanical and dose calculation uncertainties. Phys Med Biol 2015; 60: 7101-25. doi: 10.1088/0031-9155/60/18/7101ParkJMParkSYKimHModulation index for VMAT considering both mechanical and dose calculation uncertaintiesPhys Med Biol20156071012510.1088/0031-9155/60/18/710126317697Open DOISearch in Google Scholar
Park JM, Wu HG, Kim JH, Carlson JNK, Kim K. The effect of MLC speed and acceleration on the plan delivery accuracy of VMAT. Br J Radiol 2015; 88: 16-24. doi: 10.1259/bjr.20140698ParkJMWuHGKimJHCarlsonJNKKimKThe effect of MLC speed and acceleration on the plan delivery accuracy of VMATBr J Radiol201588162410.1259/bjr.20140698462847725734490Open DOISearch in Google Scholar
Glenn MC, Hernandez V, Saez J, Followill DS, Howell RM, Pollard-Larkin JM, et al. Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance. Phys Med Biol 2018; 63. doi: 10.1088/1361-6560/aae29eGlennMCHernandezVSaezJFollowillDSHowellRMPollard-LarkinJMet alTreatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performancePhys Med Biol20186310.1088/1361-6560/aae29e628726830230475Open DOISearch in Google Scholar
Abdellatif A, Gaede S. Control Point Analysis comparison for 3 different treatment planning and delivery complexity levels using a commercial 3-dimensional diode array. Med Dosim 2014; 39: 174-9. doi: 10.1016/j.meddos.2013.12.005AbdellatifAGaedeSControl Point Analysis comparison for 3 different treatment planning and delivery complexity levels using a commercial 3-dimensional diode arrayMed Dosim201439174910.1016/j.meddos.2013.12.00524480374Open DOISearch in Google Scholar
Huang L, Zhuang T, Mastroianni A, Djemil T, Cui T, Xia P. Impact of small MU/segment and dose rate on delivery accuracy of volumetric-modulated arc therapy (VMAT). J Appl Clin Med Phys 2016; 17: 203-10. doi: 10.1120/jacmp.v17i3.6046HuangLZhuangTMastroianniADjemilTCuiTXiaPImpact of small MU/segment and dose rate on delivery accuracy of volumetric-modulated arc therapy (VMAT)J Appl Clin Med Phys2016172031010.1120/jacmp.v17i3.6046569090627167278Open DOISearch in Google Scholar
Esposito M, Villaggi E, Bresciani S, Cilla S, Falco MD, Garibaldi C, et al. Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods. Radiother Oncol 2020; 149: 15867. doi: 10.1016/j.radonc.2020.05.014EspositoMVillaggiEBrescianiSCillaSFalcoMDGaribaldiCet alEstimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methodsRadiother Oncol20201491586710.1016/j.radonc.2020.05.01432416282Open DOISearch in Google Scholar
Olaciregui-Ruiz I, Beddar S, Greer P, Jornet N, McCurdy B, Paiva-Fonseca G, et al. In vivo dosimetry in external beam photon radiotherapy: Requirements and future directions for research, development, and clinical practice. Phys Imaging Radiat Oncol 2020; 15: 108-16. doi: 10.1016/j.phro.2020.08.003Olaciregui-RuizIBeddarSGreerPJornetNMcCurdyBPaiva-FonsecaGet alIn vivo dosimetry in external beam photon radiotherapy: Requirements and future directions for research, development, and clinical practicePhys Imaging Radiat Oncol2020151081610.1016/j.phro.2020.08.003780761233458335Open DOISearch in Google Scholar
Consorti R, Fidanzio A, Brainovich V, Mangiacotti F, De Spirito M, Mirri MA, et al. EPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: Initial clinical experience. Phys Medica 2017; 42: 157-61. doi: 10.1016/j.ejmp.2017.09.133ConsortiRFidanzioABrainovichVMangiacottiFDe SpiritoMMirriMAet alEPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: Initial clinical experiencePhys Medica2017421576110.1016/j.ejmp.2017.09.13329173910Open DOISearch in Google Scholar
McCurdy BMC, McCowan PM. In vivo dosimetry for lung radiotherapy including SBRT. Phys Medica 2017; 44: 123–30. doi: 10.1016/j.ejmp.2017.05.065McCurdyBMCMcCowanPMIn vivo dosimetry for lung radiotherapy including SBRTPhys Medica2017441233010.1016/j.ejmp.2017.05.06528576581Open DOISearch in Google Scholar